[144] ANI Pharmaceuticals, Inc. SEC Filing

Rhea-AI Filing Summary

ANI Pharmaceuticals (ANIP) filed a Form 144 notifying a proposed Rule 144 sale of 50,000 common shares to be handled by Morgan Stanley Smith Barney LLC on 08/12/2025 on the NASDAQ. The filing lists an aggregate market value of $4,303,590.00 and 21,699,636 shares outstanding, making the proposed sale roughly 0.23% of outstanding shares and implying an approximate price of $86.07 per share. The shares were reported as acquired the same day by stock option exercise from the issuer with cash payment. The filing reports no securities sold in the past three months. The extract does not include the filer identity or a dated signature in the provided content.

Positive

• Transaction details are explicit: 50,000 shares, aggregate value $4,303,590.00, broker identified as Morgan Stanley Smith Barney LLC
• Acquisition and payment are clear: shares acquired by stock option exercise on 08/12/2025 and paid in cash

Negative

• Filer identity is not provided in the supplied extract, limiting clarity on who is selling
• No dated signature or notice date shown in the provided content, reducing verification of the filing's execution

Insights

Financial Analyst

TL;DR: Routine Rule 144 notice for a 50,000-share proposed sale; appears immaterial to capital structure given numbers provided.

The Form 144 discloses a proposed sale of 50,000 common shares with an aggregate market value of $4,303,590.00 to be executed through Morgan Stanley Smith Barney LLC on 08/12/2025. With 21,699,636 shares outstanding, the notice represents approximately 0.23% of outstanding shares and implies an approximate per-share level of $86.07 based on the stated market value. The shares were acquired via stock option exercise on 08/12/2025 and paid for in cash. No sales in the prior three months are reported. Based solely on the filing extract, there is no clear indication of a material market impact.

Corporate Governance Expert

TL;DR: Filing shows a disclosed proposed sale but lacks identifying signature and filer details in the provided extract, limiting governance signal.

The Form 144 provides transaction specifics (broker, share count, acquisition method, payment type, aggregate value, and sale date) but the provided content does not include the name of the person for whose account the securities are to be sold, nor a visible signature or date of notice. The form also includes the standard representation about material adverse information and trading-plan language, but no plan adoption date or signer is present in the extract. This omission reduces the ability to assess insider intent or governance context from the supplied text alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	50000	4303590.00	21699636	08/12/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/12/2025	Stock Option Exercise	Issuer			50000	08/12/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the ANIP Form 144 disclose?

The filing notifies a proposed sale of 50,000 common shares under Rule 144 with an aggregate market value of $4,303,590.00.

Who is the broker handling the proposed ANIP sale?

Morgan Stanley Smith Barney LLC (Executive Financial Services, 1 New York Plaza 8th Floor New York NY 10004) is listed as the broker.

When is the proposed sale date for the ANIP shares?

Approximate date of sale: 08/12/2025 as stated in the filing.

How were the 50,000 ANIP shares acquired?

Acquired by stock option exercise on 08/12/2025 from the issuer with payment listed as cash.

What portion of ANIP outstanding shares does this notice represent?

Approximately 0.23% of outstanding shares based on 50,000 shares versus 21,699,636 shares outstanding.

Does the filing show any securities sold in the past three months for ANIP?

Nothing to Report for securities sold during the past three months in the provided content.

Does the extract identify the seller or include a signature?

The supplied extract does not include the seller's identity or a dated signature in the visible content.